Basic Research Open Access
Copyright ©The Author(s) 2002. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jun 15, 2002; 8(3): 511-514
Published online Jun 15, 2002. doi: 10.3748/wjg.v8.i3.511
Effects of Yigan Decoction on proliferation and apoptosis of hepatic stellate cells
Xi-Xian Yao, Dong-Mei Yao, Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China
You-Wei Tang, He-Ming Xiu, Department of Geriatrics, Bethune International Peace Hospital, Shijiazhuang 050082, Hebei Province, China
Author contributions: All authors contributed equally to the work.
Supported by Hebei Province Administration Bureau of TCM, No. 200001
Correspondence to: Dr. Xi-Xian Yao, Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei Province, China. yaoxixian@263.net
Telephone: +86-311-7814356
Received: June 3, 2001
Revised: July 23, 2001
Accepted: December 8, 2001
Published online: June 15, 2002

Abstract

AIM: To investigate the effects of Chinese herb Yigan Decoction on proliferation and apoptosis of the hepatic stellate cells (HSC) in vitro.

METHODS: The study in vitro was carried out in the culture of HSC lines. Various concentrations of Yigan Decoction were added and incubated. Cell proliferation was detected with MTT colorimetric assay. Cell apoptosis was detected by electron microscopy, flow cytometry and TUNEL.

RESULTS: The proliferation of HSC was inhibited by Yigan Decoction, which depending on dose and time significantly. The HSC proliferation rates of groups at the end concentrations 144 and 72 (g·L-1) were 21.62% and 40.54% respectively, significantly lower than that of normal control group (P < 0.01). The HSC proliferation rates of groups at the end concentrations 36, 18 and 9 (g·L-1) were 54.05%, 45.95% and 51.35% respectively, lower than that of control group (P < 0.05). When the end concentration was 4.5 g·L-1, the proliferation rate was 83.78%, which appeared no significant differences compared with control group. At the same concentrations of 18 g·L-1, the inhibitory effects of Yigan Decoction at 24 h, 48 h and 72 h time point were observed, the effects were time-dependent, and reached a peak at 72 h. Meanwhile, it was showed that the inducing effects of Yigan Decoction on HSC apoptosis were dose-dependent and time-dependent. The apoptosis index (AI) was detected by TUNEL. After Yigan Decoction had been incubated for 48 h at the end concentration of 18 g·L-1, the AI (14.5 ± 3.1)% was significantly higher than that of control group (4.3 ± 1.3)% (P < 0.01). When visualized under transmission electron microscopy, some apoptotic stellate cells were found, i.e. dilated endoplasmic reticulum, irregular nuclei, chromatin condensation and heterochromatin ranked along inside of nuclear membrane. By flow cytometry detection, after HSC was treated with Yigan Decoction at different concentrations of 36, 18 and 9 (g·L-1) for 48 h, AI (%) were 13.3 ± 3.2, 10.7 ± 2.7 and 10.1 ± 2.5 respectively, which were significantly higher than that of control group (4.1 ± 1.9) (P < 0.01). At the same concentration of 18 g· L-1 for 24 h, 48 h and 72 h, AI (%) were 9.3 ± 1.8, 10.7 ± 2.7 and 14.6 ± 4.3 respectively, which were significantly higher than that of control group (P < 0.01).

CONCLUSION: Yigan Decoction could significantly inhibit HSC proliferation and increase the apoptosis index of HSC dose-dependently and time-dependently, which may be related to its mechanism of antifibrosis.




INTRODUCTION

As the mechanisms of hepatic fibrosis have been gradually clarified and thus, many attempts to treat hepatic fibrosis have been made recently. But up to date there is still no effective way to treat hepatic fibrosis[1]. Recent insights[2-11] into the molecular pathogenesis of hepatic fibrosis and the efficacy of TCM have provided hope for the foreground of successful therapy, such as compound 861[12], Kangxianfang[13], Fuzhenghuayu decoction[14-16], Ganyanping[17] etc. Yigan Decoction, which was designed in our lab, was used in clinical setting for nearly twenty years. Our clinical practice has revealed that it has a marked curative effect on treating chronic liver diseases[18]. Hepatic sinusoidal cells such as the hepatic stellate cells (HSC), endothelial cells or Kupffer cells are deeply involved in hepatic fibrogenesis or fibrolysis. Recent studies have made their morphology and functions clear. A wealth of evidence now indicates that HSC is the key to produce fibrosis which served as the major source of fibrillar and nonfibrillar matrix proteins. Quiescent HSC synthesize low levels of matrix proteins, but as a result of injury, HSC could be proliferated and transformed to myofibroblast, a process termed activation[4]. So to inhibit HSC activation and proliferation and induce apoptosis of the activated HSC is one of the most important strategies for preventing and curing liver fibrosis. HSC cultured in uncoated plastic plates in vitro spontaneously undergo activation and share the similar features of cell activation in vivo[19]. This culture-induced activation has been extensively studied as a model of the activation secondary to liver fibrogenesis. In order to testify the action of Yigan Decoction on liver fibrosis and investigate its mechanism, the effects of Chinese herb Yigan Decoction on the proliferation and apoptosis of HSC in vitro were observed.

MATERIALS AND METHODS
Cell culture

HSC lines (CFSC) (established by Professor Greenwel) were provided by Southwest Hospital, Third Military Medical University. The phenotype was activated HSC[20,21]. Cells were cultured in RPMI1640 (Gibco) medium plus 100 mL·L-1 fetal calf serum, penicillin 1 × 105 U·L-1 and streptomycin 100 mg·L-1, and kept in a controlled atmosphere (5% CO2) incubator at 37 °C.

Drug treatment

Yigan Decoction consists of Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Paeoniae Rubra and Hirudo, etc. The decoction was made by Hebei Institute of Gastroenterology, containing 0.72 g of crude herbs in each milliliter. Exponentially growing cells were seeded in plates for 24 h and treated with Yigan Decoction at various concentrations (144, 72, 36, 18, 9 and 4.5 g·L-1) for 24 h, 48 h and 72 h, respectively. The cells not treated with this drug served as control cells.

Dose-dependent effects of Yigan Decoction on cell proliferation

Colorimetric MTT assays[23] were used to observe cell proliferation. HSC were incubated in 96 well plates. The concentration of cells was modulated to 1 × 108·L-1. After cultured for 24 h, Yigan Decoction was added in different concentrations such as 144, 72, 36, 18, 9 and 4.5 (g·L-1) for 48 h. Each group was arranged three duplicate wells. After the supernatant was extracted and 0.05% MTT solution 10 ìL was added to all wells for 4 h, DMSO 100 μL was added for coloration. After a few minutes at room temperature to ensure that all crystals were dissolved, the optic-metric density (OD) was read on ELISA reader at test wavelength of 570 nm and referent wavelength of 630 nm.

Time-dependent effects of Yigan Decoction on cell proliferation

The cultured cells were grown up to logarithmic growth phase, digested with 2.5 g·L-1 trypsin. The concentration of cells was modulated to 1 × 108·L-1. HSC were incubated in 24 well plates. Each well was added with 1 mL. After being cultured for 24 h, Yigan Decoction (50 μL) was added into wells at the same end concentration of 18 g·L-1. Cell proliferation was observed at different times, i.e., 24 h, 48 h and 72 h after the herb was treated, each was arranged three duplicate wells. The number of HSC was counted at the end of each time.

Apoptosis examined by TUNEL

In situ cell death detection kits were purchased from Boehringer Mannheim Company, Germany. The cells were adjusted to a density of 2 × 103 cells/cm2, added to 24-well plates with cover glass-slides in 0.5 mL each well. After being incubated with Yigan Decoction at the end concentration of 18 g·L-1 for 48 h, the glass slides were taken out, rinsed, fixed and stained. The negative control with omission of TUNEL enzyme was designed according to the manufacturer’s manual. The cells stained with dark brown nucleus were considered as positive cells. Ten optical fields, about 500-1000 cells were selected randomly and counted in each glass-slide under the high magnification (× 400) microscope. Apoptosis Index (AI) = (apoptotic cells/total cells) × 100%.

Apoptosis examined by transmission electron microscopy

HSC were treated with Yigan Decoction at the end concentration of 18 g·L-1 for 48 h. Then the cells were centrifugated and fixed in glutaraldehyde for observation of transmission electron microscopy.

Apoptosis examined by flow cytometry

HSC were treated with Yigan Decoction at the end concentration of 36, 18 and 9 (g·L-1) for 24 h, 48 h and 72 h. Cells were digested by 2.5 g·L-1 trypsin, washed by PBS, fixed by cold ethanol at 4 °C and dyed with PI (propidium iodide), and then were analyzed by flow cytometry.

Statistics

Results were expressed as mean ± SD (-x ± s). Differences between groups and differences over times were analyzed using analysis of variance and Newman-Keuls methods where appropriate. P values less than 0.05 were considered to be statistically significant.

RESULTS
Dose-dependent inhibitory effects of Yigan Decoction on cell proliferation

Yigan Decoction could significantly inhibit HSC proliferation dose-dependently compared with the control group (Table 1). The inhibitory effects of groups at concentrations of 144 and 72 (g·L-1) were stronger than those of groups at concentrations of 36, 18 and 9 (g·L-1), and no obvious inhibitory effect was found at the herb concentration of 4.5 g·L-1.

Table 1 Effects of Yigan Decoction on HSC proliferation (-x±s).
GroupsHerb concentrations (g·L-1)ODsproliferation rates (%)
Yigan Decoction1440.08 ± 0.02b21.62
720.15 ± 0.04b40.54
360.20 ± 0.03a54.05
180.17 ± 0.02a45.95
90.19 ± 0.05a51.35
4.50.31 ± 0.0483.78
Control0.37 ± 0.03100
Time-dependent inhibitory effects of Yigan Decoction on cell proliferation

At the end concentration of 18 g·L-1, HSC were significantly inhibited compared with control group. The number of cells was manually counted. The effect was time-dependent, and reached a peak at 72 h (P < 0.01) (Table 2).

Table 2 Effects of Yigan Decoction on HSC proliferation (× 108·L-1) (-x±s).
Groups24 h48 h72 h
Control1.440 ± 0.1242.288 ± 0.1782.335 ± 0.146
Yigan Decoction1.203 ± 0.1121.258 ± 0.098b1.359 ± 0.079b
Apoptosis of HSC induced by Yigan Decoction examined by TUNEL

Based on the above results that Yigan Decoction could inhibit HSC proliferation at concentrations of 9-144 g·L-1 from 24 h to 72 h, we selected the 18 g·L-1 of Yigan Decoction and 48 h affecting period as experimental conditions so as to better compare with the results of the herb on HSC lines. After Yigan Decoction had been incubated for 48 h, the AI 22.5 ± 7.1% was significantly higher than that of control group 4.3 ± 1.3% (P < 0.01). Apoptotic cell is characterized by compaction of nuclear chromatin and condensation of cytoplasm. By TUNEL stain the most condensed cells demonstrated evidence of DNA fragmentation and were strongly stained (Figure 1, arrowed).

Figure 1
Figure 1 (A) Control HSC (TUNEL × 400). (B) Apoptotic cell characterized by compaction of nuclear chromatin and condensation of cytoplasm (TUNEL × 400). By TUNEL stain the most condensed cells demonstrated evidence of DNA fragmentation and were strongly staining (iü).
Apoptosis of HSC induced by Yigan Decoction examined by transmission electron microscopy

After 24-48 h treatment of Yigan Decoction, we visualized under inverted microscopy. Small rounded cells were observed on the surface of the monolayer. These cells could be displaced by agitation of the tissue culture plate, demonstrating that they were very loosely adherent to the monolayer and that some were detached and floating in the culture supernatant (Figure 2). These features are compatible with HSC that have undergone programmed cell death or apoptosis[24]. When visualized under transmission electron microscopy, the apoptotic HSC were found, i.e. dilated endoplasmic reticulum, irregular nuclei, chromatin condensation and heterochromatin ranked along inside of nuclear membrane. All of these features are characteristic of apoptosis and distinguish programmed cell death from necrosis (Figure 3).

Figure 2
Figure 2 Morphological changes of HSC observed by light microscopy treated by Yigan Decoction. (A) Untreated cells (× 200); (B) some HSC got round, detached and floating in the culture supernatant after exposure to 18 g·L-1 Yigan Decoction for 48 h (× 100).
Figure 3
Figure 3 Ultrastructures of HSC with or without treatment with Yigan Decoction. Following 48 h treatment of Yigan Decoction, dilated endoplasmic reticulum, irregular nuclei, chromatin condensation and heterochromatin ranked along inside of nuclear membrane could be found (A 5000 ×). Untreated cells (B 5000 ×).
Apoptosis examined by flow cytometry

After HSC were treated with Yigan Decoction at different concentrations of 36, 18 and 9 (g·L-1) for 48 h, the apoptosis rate was significantly higher than that of control group (P < 0.01) (Table 3). Our experiments showed that Yigan Decoction could increase the apoptosis rate dose-dependently and time-dependently compared with the control group. (Table 3 and Table 4, Figure 4).

Table 3 Apoptosis indexes of Yigan Decoction on HSC (-x±s).
GroupsHerb concentrations (g·L-1)apoptosis indexes (%)
Yigan Decoction3613.3 ± 3.2b
1810.7 ± 2.7b
910.1 ± 2.5b
Control4.1 ± 1.9
Table 4 Time-dependent effects of Yigan Decoction on HSC apoptosis (-x±s).
Groups24 h48 h72 h
Control4.5 ± 1.37.1 ± 1.98.0 ± 1.8
Yigan Decoction9.3 ± 1.8b10.7 ± 2.7b14.6 ± 4.3b
Figure 4
Figure 4 Flow cytometry changes. (A) Control group. (B) Yigan Decoction group.
DISCUSSION

Recent studies have found clearly the key role of HSC in developing liver fibrosis. HSC could activate, proliferate and largely synthesize various components of extracellular matrix in chronic liver disease, that would lead to liver fibrosis[22]. Studies suggest that HSC numbers are controlled by apoptosis in addition to proliferation during progressive fibrosis and particularly during recovery from fibrosis. The key event in the process of injury-fibrosis-recovery sequence is the loss of activated HSC mediated by apoptosis[23]. Therefore to induce apoptosis of activated HSC is one of the most important therapeutic strategies for liver fibrosis. Recent evidence has demonstrated that a mechanism to eliminate activated HSC in culture and in animal models is inducing apoptosis. Interestingly, activated HSC are more sensitive to some mechanisms of apoptosis than quiescent HSC. Such a mechanism may serve in the future to eliminate the undesirable activated HSC without affecting their normal quiescent counterpart.

The CFSC used in present study is activated HSC. So it shared some features with activated HSC in vivo and could be used as a desirable cell model for the test of antifibrotic drugs. Although the desirable antifibrotic drugs have not been found up to now, some herbal decoctions have been reported to prevent fibrogenesis effectively, showing a good prospect of using Chinese herbs in treating chronic liver diseases[24]. It was reported that Radix Salviae Miltiorrhizae (RSM) can inhibit fibroblast cells[25]. RSM can prevent liver fibrosis if it is used for a long time[26]. Large doses of RSM can activate collagenase and help reduce extracellular matrix. The level of P III P and laminin were decreased in patients with liver disease after treatment of RSM. Studies demonstrated that long-term treatment of RSM for 10-12 wk can reduce portal vein, spleen diameters and blood flow, but the velocity of blood flow did not change[27]. These results demonstrated the advantage of Chinese herbs in treating chronic hepatic diseases. Yigan Decoction, one of formally produced herbs, could prevent extracellular matrix production and deposit in CCl4 induced rat liver fibrosis[28], and improve fibrotic liver structure and liver function in patients with chronic hepatitis or cirrhosis[18]. It is mainly composed of RSM, Radix Angelicae Sinensis (RAS), Radix Paeoniae Rubra and Hirudo, which have the actions of promoting blood circulation, removing blood stasis, shrinking the liver and spleen.

The present results suggest that Yigan Decoction could significantly inhibit HSC proliferation and increase the apoptosis rate of HSC dose-dependently and time-dependently compared with the control group (P < 0.01). After Yigan Decoction had been incubation for 48 h, the apoptosis rate of HSC was 27.5% compared with 7.1% in the control group (P < 0.01). Our findings strongly suggest that inhibition of HSC proliferation and induction of HSC apoptosis may play an important role in the antifibrotic actions of Yigan Decoction. Our data may provide a new idea for the future development of therapeutic antifibrotic strategies by means of traditional Chinese medicine.

The antifibrotic effect of Yigan Decoction has been well proved by the results of experimental and clinical studies. However, Chinese herbs have very complicated components and their metabolisms are not well clarified yet. There’s still a long way to go. With the ever-increasing in-depth studies about the pharmacodynamics, pharmacokinetics, reasonable combinations of drugs, the best preparation form and dosages of each herb and courses, Yigan Decoction is expected to be an effective antihepatofibrotic drug.

Footnotes

Edited by Hu DK

References
1.  Brenner DA. Therapeutic strategy for liver fibrosis. J Gastroenterol Hepatol. 1999;14:A279-A280.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Wu CH. Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesis. World J Gastroenterol. 1999;5:388-390.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Liu CH, Hu YY, Wang XL, Liu P, Xu LM. Effects of salvianolic acid-A on NIH/3T3 fibroblast proliferation, collagen synthesis and gene expression. World J Gastroenterol. 2000;6:361-364.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 1993;328:1828-1835.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 793]  [Cited by in F6Publishing: 876]  [Article Influence: 28.3]  [Reference Citation Analysis (0)]
5.  Liu SR, Gu HD, Li DG, Lu HM. A comparative study of fat storing cells and hepatocytes in collagen synthesis and collagen gene expression. Xin Xiaohuabingxue Zazhi. 1997;5:761-762.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Gu SW, Luo KX, Zhang L, Wu AH, He HT, Weng JY. Relationship between ductile proliferation and liver fibrosis of chronic liver disease. Shijie Huaren Xiaohua Zazhi. 1999;7:845-847.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Yan JC, Ma Y, Chen WB, Shun XH. Dynamic observation on liver fibrosis and cirrhosis of hepatitis B. Huaren Xiaohua Zazhi. 1998;6:699-702.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Wang Y, Gao Y, Huang YQ, Yu JL, Fang SG. Gelatinase A proenzyme expression in the process of experimental liver fibrosis. Shijie Huaren Xiaohua Zazhi. 2000;8:165-167.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Lu LG, Zeng MD, Li JQ, Qiu DK, Hua J, Fan ZP. Expression of intercellular adhesion molecular-1 by activated hepatic stellate cells. Huaren Xiaohua Zazhi. 1998;6:567-569.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Wang X, Chen YX, Xu CF, Zhao GN, Huang YX, Wang QL. Relationship between tumor necrosis factor-alphaand liver fibrosis. World J Gastroenterol. 1998;4:18.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Cheng ML, Wu YY, Huang KF, Luo TY, Ding YS, Lu YY, Liu RC, Wu J. Clinical study on the treatment of liver fibrosis due to hepatitis B by IFN-alpha(1) and traditional medicine preparation. World J Gastroenterol. 1999;5:267-269.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  You H, Wang B, Wang T. [Proliferation and apoptosis of hepatic stellate cells and effects of compound 861 on liver fibrosis]. Zhonghua Gan Zang Bing Za Zhi. 2000;8:78-80.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Wu JG, Li XY. Clinical studies of Kangxianfang in treating liver cirrhosis. Xin Xiaohuabingxue Zazhi. 1997;5:303-304.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Hu YY, Liu C, Liu P, Gu HT, Ji G, Wang XL. Anti-fibrosis and anti-peroxidation of lipid effects of Fuzhenghuayu decoction on rat liver induced by CCl4. Xin Xiaohuabingxue Zazhi. 1997;485-486.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Gu HT, Hu YY, Xu LM, Liu P, Liu C. Pathological observation on effects of Fuzhenghuayu decoction on rat liver induced by CCl4. Zhongxiyi Jiehe Ganbing Zazhi. 1997;7:224-226.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Liu P, Liu C, Xu LM, Hu YY, Xue HM, Liu CH, Zhang ZQ. Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. World J Gastroenterol. 1998;4:348-353.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Du LJ, Tang WX, Dan ZL, Zhang WY, Li SB. Protective effect of Ganyanping on CCl4 induced liver fibrosis in rats. Huaren Xiaohua Zazhi. 1998;6:21-22.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Yao XX, Fu YL, Li XL, Jia YP, An ZC, Zhang XZ. Therapeutic effect of Yigan Decoction on chronic hepatitis: a multi-center observation of 324 cases. Hebei Yixueyuan Xuebao. 1989;10:231-233.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Friedman SL. Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis. 1990;10:20-29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 150]  [Cited by in F6Publishing: 152]  [Article Influence: 4.5]  [Reference Citation Analysis (1)]
20.  Zhu YH, Hu DR. Establishment and application of hepatic stellate cells. Shijie Huaren Xiaohua Zazhi. 1999;7:348-349.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89:271-277.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3523]  [Cited by in F6Publishing: 3615]  [Article Influence: 95.1]  [Reference Citation Analysis (0)]
22.  Bissell DM, Friedman SL, Maher JJ, Roll FJ. Connective tissue biology and hepatic fibrosis: report of a conference. Hepatology. 1990;11:488-498.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 98]  [Cited by in F6Publishing: 91]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
23.  Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest. 1998;102:538-549.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 785]  [Cited by in F6Publishing: 806]  [Article Influence: 31.0]  [Reference Citation Analysis (0)]
24.  Jia K. [Pay more attention to the study of the treatment of hepatitis B]. Zhonghua Nei Ke Za Zhi. 2000;39:797-798.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Yao XX, Li XT, Li YW, Zhang XY. Clinical and experimental study of Radix Salviae Miltiorrhizae and other Chinese herbs of blood-activating and stasis-eliminating effects on hemodynamics of portal hypertension. Zhonghua Xiaohua Zazhi. 1998;18:24-27.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Yao XX, Cui DL, Sun YF, Li XT. Clinical and experimental study of effect of Raondix Salviae Militiorrhiza and other blood-activating and stasis-eliminating Chinese herbs on hemodynamics of portal hypertension. World J Gastroenterol. 1998;4:439-442.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Li XT, Bai WY, Wang HM, Yao XX. Study of effects of Radix salviae miltiorrhizae on portal hypertension in experimental cirrhotic dogs. Xin Xiaohuabingxue Zazhi. 1997;5:421-422.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Yao XX, Tang YW, Yao DM, Xiu HM. Effect of Yigan Decoction on the expression of type I, III collagen proteins in experimental hepatic fibrosis in rats. Shijie Huaren Xiaohua Zazhi. 2001;9:263-267.  [PubMed]  [DOI]  [Cited in This Article: ]